Customer Inquiries:153-706-17733
Business Call:86-513-83444258

关于双林

Latest News

Notice on Pharmaceutical GMP Compliance Inspection

2026-03-10

Jiangsu Provincial Drug Administration – Notice of Approval for Re-registration of Chemical Active Pharmaceutical Ingredients

2026-03-02

Xinhua News Agency reports that a Chinese innovative pharmaceutical company has overcome a major challenge in the treatment of osteoarthritis. The world's first potassium salt type glucosamine sulfate drug has been launched.

2025-07-02

Economic Information Daily: Chinese innovative pharmaceutical companies break through the treatment difficulties of osteoarthritis, and the world's first potassium salt type glucosamine sulfate drug is launched

2025-07-02

China News reports that a Chinese innovative pharmaceutical company has overcome a major challenge in the treatment of osteoarthritis. The world's first potassium salt type glucosamine sulfate drug has been launched.

2025-07-02

Jiangsu Shuanglin Marine Biological Pharmaceutical Co., Ltd.

Customer consultation telephone
4008-809-776
TEL:+86-513-83444258
E-mail：warren@china-shuanglin.com
ADD: Intersection of Hecheng North Road and Route 328, Lvsi Port Town, Qidong City, Jiangsu Province, China

Home page

Jiangsu Shuanglin Marine Biological Pharmaceutical Co., Ltd.

Customer Consultation Telephone： 4008-809-776
TEL：+86-513-83444258
E-mail：sl@china-shuanglin.com
E-mail：warren@china-shuanglin.com
ADD：Intersection of Hecheng North Road and Route 328, Lvsi Port Town, Qidong City, Jiangsu Province

http://www.china-shuanglin.com/ Jiangsu Shuanglin Marine Biological Pharmaceutical Co., Ltd., welcome to inquire:+86-513-83444258

苏公网安备32068102810382号

Jiangsu Shuanglin Marine Biological Pharmaceutical Co., Ltd.

Business License